Furthermore, combining CSF1R or STAT3 inhibitors with radiotherapy, chemotherapy, or oncolytic virotherapy has also been shown to bolster antitumor immune responses and presents new possibilities for overcoming GBM resistance [88]. Here, STAT3 is linked to glioblastoma.